Eckert & Ziegler plans to re-enter U.S. market

Radiation technology company Eckert & Ziegler is planning to re-enter its radiation therapy division the U.S. market by way of a strategic alliance with brachytherapy treatment information group Core Oncology of Santa Barbara, Calif.

Via the terms of the partnership, both companies will cross-market their products and determine further research and development programs, said the Belgium-based IBt Bebig, which is a subsidiary of Eckert & Ziegler.

IBt Bebig has made an initial investment of $2 million in Core Oncology in the form of a subordinated loan maturing before 2010, which the company hopes will help to expand revenues in the therapy segment.

Around the web

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.